DiabetesEmpagliflozin 25mg + Linagliptin 5mgSGLT2 Inhibitor + DPP-4 Inhibitor CombinationsType 2 Diabetes
Prescription Required
Brand: Glyxambi
Glyxambi 25mg/5mg Tablets 30’s (10’s Blister × 3)
Prescription only
Glyxambi 25mg/5mg Tablets contain empagliflozin and linagliptin, a prescription combination used to improve blood glucose control in adults with type 2 diabetes. Empagliflozin increases urinary glucose removal, while linagliptin supports glucose-dependent insulin release and reduces glucagon secretion.
- Active Ingredients: Empagliflozin 25mg + Linagliptin 5mg
- Used For: Management of blood glucose levels in adults with type 2 diabetes mellitus.
- Medicine Type: Prescription SGLT2 inhibitor and DPP-4 inhibitor combination tablets.
This product is a prescription-only medicine and should be used only as directed by a licensed healthcare professional. Always follow your doctor's recommendations and the instructions on your prescription label.
- Take the tablets exactly as prescribed.
- Swallow with water.
- Follow the glucose-monitoring, dietary and fluid instructions provided by your healthcare professional.
- Do not change or stop treatment without medical advice.
- Continue any recommended blood glucose and kidney-function monitoring.
- Do not share this medicine with others.
- Use only for the condition for which it was prescribed.
- Keep out of reach of children.